Abstract B017: Immune engineering to enhance CAR T cell trafficking in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal malignancies in the United States, largely due to its resistance to conventional treatments. Although immunotherapies have revolutionized the treatment landscape for hematological malignancies, their translation to solid tumors such as PDA remains...